Skip to main
SHC

Sotera Health (SHC) Stock Forecast & Price Target

Sotera Health (SHC) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 67%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Sotera Health is well-positioned for growth, with strong financial performance, a diverse portfolio of services, and a solid presence in key markets such as the United States, Canada, and Europe. The company has also taken steps to address legal concerns and is poised to capitalize on potential growth opportunities in the future. Its competitive advantage in the sterilization and lab testing industries, along with positive trends in revenue, adjusted EBITDA, and cash flow, make it a promising investment option.

Bears say

Sotera Health is facing some legal and environmental risks, but the company's strong financial profile and recurring revenue from its two core businesses make it an attractive investment opportunity. Additionally, its subsidiary Nordion is expected to drive future growth with its specialized services. However, careful monitoring of potential legal and environmental challenges is necessary for this investment.

Sotera Health (SHC) has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 67% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sotera Health (SHC) Forecast

Analysts have given Sotera Health (SHC) a Buy based on their latest research and market trends.

According to 6 analysts, Sotera Health (SHC) has a Buy consensus rating as of May 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sotera Health (SHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.